Optimizing the DMTA Cycle: Closing the Gap Between AI and Pharma R&D
Manual data translation limits AI, but connecting the DMTA cycle turns scattered data into actionable knowledge
Advertisement
Manual data translation limits AI, but connecting the DMTA cycle turns scattered data into actionable knowledge
Advertisement
A detailed look at accelerated year-end QC needs and how third-party labs deliver compliance, safety, and fast turnaround for seasonal manufacturing
Join us and Waters' Duanduan Han, PhD, to explore how LC-UV/MS workflow can help labs meet safety and regulatory standards for GLP-1 analogs
Biosimilars represent a promising opportunity to enhance healthcare affordability and accessibility by providing alternatives to costly biologic therapies.
Join Michael's talk at the 2025 Outsource! Week for tips on how to decide if method validation or verification suits your product
Register today to access these curated webinars live or on demand
Investing in early phase potency assays and RMMs and aligning with GMP modernization can future-proof pharma testing labs
Global compliance depends on precise, reproducible chemistry testing built on accredited analytical methods
Labs are under pressure to deliver results that are not only accurate but also traceable, defensible, and structured for global compliance.
What contract labs need to know about ultra-trace PFAS detection methods, sampling control, and evolving compliance standards
How contract labs support compounding pharmacies with sterility, potency, and compliance testing under USP <797>
Advertisement
Advertisement